Loading viewer...
investor_presentation
Format: PDF investor_presentation
Axonics presents its sacral neuromodulation (SNM) system technology and market position. The company focuses on delivering customer-centric solutions to treat urinary and bowel dysfunction in adults through innovative medical devices.
investor_presentation
45 Pages
Collegium Pharmaceutical
Disney Shareholder Value Strategy 2024
investor_presentationinvestor_presentation
67 Pages
The Walt Disney Company
investor_presentation
KBC Group